I-MAB

Live / Registered — Registered (as of 11 Jan 2022)

What this means for you

Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Jan 2028: the §8 declaration of use).

Record

Serial number
88480086
Registration number
6615802
Mark type
Word mark
Filed
19 Jun 2019
Published for opposition
17 Aug 2021
Registered
11 Jan 2022
Next maintenance filing
§8 declaration of use, due by 11 Jan 2028 (grace period to 11 Jul 2028)
Attorney of record
Jacqueline Lesser

Goods and services

  • Class 005 — Pharmaceuticals: Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies

Owner

Board proceedings on this mark

The owner also pleads this mark in 1 other Board proceeding.

Prosecution history

  • 01 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 01 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 01 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 16 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 16 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 16 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 25 Dec 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 17 May 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
  • 10 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 09 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 09 Dec 2021 — EXAMINER'S AMENDMENT ENTERED
  • 09 Dec 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

View this trademark record on Rightsy